接受调强放疗的鼻咽癌患者颞叶坏死预测模型的开发与验证
本研究利用2009年256例鼻咽癌患者构建颞叶坏死(TLN)定量预测模型,并在2010年493例连续患者中验证。模型仅含D0.5cc与D10两个剂量学特征,与TLN状态显著相关(训练集与测试集P均<.001),测试集C-index为0.685(95%CI:0.6048-0.765)。临床因素对TLN无直接预测价值。
要点
- 基于D0.5cc与D10的预测模型与颞叶坏死状态显著相关(两队列P均<.001)。
- 测试集区分度C-index为0.685(95%CI:0.6048-0.765),校准趋势一致。
- 年龄、性别、T/N分期、总分期、糖尿病、高血压等临床因素无直接预测价值。
核心结论
- 本研究提出的预测模型可便捷用于鼻咽癌患者颞叶坏死的个体化预测。
- 临床因素对颞叶坏死无直接影响。
研究设计与样本
- 预测模型在2009年1月至2009年12月256例鼻咽癌患者组成的训练队列中开发,提取剂量学与临床因素用于建模。
- 采用LASSO回归进行特征选择与预测模型构建。
- 验证队列为2010年1月至2010年12月493例连续患者,用于模型验证,评估校准度与区分度。
主要发现
- 由D0.5cc和D10两个剂量学特征构成的预测模型与颞叶坏死状态显著相关,训练队列P<.001,测试队列P<.001。
- 所有临床因素均未显示出直接预测价值。
- 模型区分度良好,测试集C-index为0.685(95%CI:0.6048-0.765),测试集校准趋势一致。
关键数值与推荐
- 预测模型包含两个剂量学特征:D0.5cc与D10。
- 训练队列256例,验证队列493例连续患者。
- 测试集C-index为0.685(95%CI:0.6048-0.765)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and validate a quantitative complication model of temporal lobe necrosis (TLN). To analyze the effect of clinical and dosimetric factors on TLN. PATIENTS AND METHODS: In this study the prediction model was developed in a training cohort that consisted of 256 nasopharyngeal carcinoma (NPC) patients from January 2009 to December 2009. Dosimetric and clinical factors were extracted for model building. Dosimetric factors including the maximum dose, minimum dose, mean dose, dose covering specific volume and dose of percentage volume. Clinical factors include age, gender, T/N-stage, overall stage, diabetes and hypertension. LASSO (least absolute shrinkage and selection operator) regression model was used for feature selection, and prediction model building. A testing cohort containing 493 consecutive patients from January 2010 to December 2010 was used for model validation. The performance of the prediction model was assessed with respect to its calibration, discrimination. RESULTS: The prediction model, which consisted of two dosimetric features (D0.5cc and D10), is significantly associated with LN status (P < .001 for both training and testing cohorts). None of clinical factors show direct prediction value. The model shows good discrimination, with a C-index of 0.685 (95% CI: 0.6048-0.765) on testing set, and a consistent trend in calibration on testing set. CONCLUSION: This study presents a prediction model can be conveniently used to facilitate the individualized prediction of TLN in patients with NPC. Clinical factors have no direct impact on TLN.
引用
- Wang J, Miao Y, Ou X, et al. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy. Radiat Oncol. 2019. PMID: 30866964. doi:10.1186/s13014-019-1250-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。